New data from a trial of an investigational mRNA vaccine shows that it reduced the risk of recurrence of the serious skin cancer melanoma when combined with immunotherapy, according to drugmakers Moderna and Merck.

Topics:  health   
RELATED ARTICLES
    BING NEWS:
    • Moderna: From Breakthrough COVID-19 Vaccines To Personalized Cancer Therapies
      Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors. See why MRNA stock is a Buy.
      01/2/2025 - 6:28 pm | View Link
    • More

     

    Welcome to Wopular!

    Welcome to Wopular

    Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

    Senh Duong (Founder)
    Wopular, MWB, RottenTomatoes

    Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

    MoviesWithButter : Our Sister Site

    More Health News